HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use APTIVUS safely and effectively. See full prescribing information for APTIVUS. APTIVUS® (tipranavir) capsules APTIVU

First Page		Document Content
Date: 2009-03-31 14:10:23 Tipranavir Lopinavir/ritonavir Ritonavir Lopinavir Saquinavir Atazanavir Antiretroviral drug Norfloxacin Trazodone Protease inhibitors Chemistry Organic chemistry		HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use APTIVUS safely and effectively. See full prescribing information for APTIVUS. APTIVUS® (tipranavir) capsules APTIVU Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 364,08 KB Share Document on Facebook

	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INVIRASE safely and effectively. See full prescribing information for INVIRASE. INVIRASE® (saquinavir mesylate) cap DocID: 1mfvE - View Document
	SUPPLEMENT ARTICLE Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs Stefan Mauss1 and Hartwig Klinker2 1 DocID: 1giaR - View Document
	Update 150 TRENDS in Microbiology DocID: 1gedP - View Document
	Research Letters AIDS 2005, 19:529–533 Virtual screening of HIV-1 protease inhibitors against human cytomegalovirus protease using docking and molecular dynamics DocID: 1gdqP - View Document
	1858 AIDS 2004, Vol 18 No 13 the rash eventually resolved. Atenolol and pantoprazole were reintroduced progressively along with zidovudine, DocID: 1fYt5 - View Document